Induction of Protective Immunity against Toxoplasma gondii in Mice by Nucleoside Triphosphate Hydrolase-II (NTPase-II) Self-amplifying RNA Vaccine Encapsulated in Lipid Nanoparticle (LNP)

Induction of Autophagy interferes the tachyzoite to bradyzoite transformation of Toxoplasma gondii

(2016) XIANGZHI LI et al.   PARASITOLOGY

Vaccines againstToxoplasma gondii: new developments and perspectives

(2013) Nian-Zhang Zhang et al.   Expert Review of Vaccines

Formulated Minimal-Length Synthetic Small Hairpin RNAs Are Potent Inhibitors of Hepatitis C Virus in Mice With Humanized Livers

(2013) Han Ma et al.   GASTROENTEROLOGY

Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice

(2013) Armin Hekele et al.   Emerging Microbes & Infections

Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses

(2012) Daniel X. Johansson et al.   PLoS One

Nonviral delivery of self-amplifying RNA vaccines

(2012) A. J. Geall et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Vaccines againstToxoplasma gondii: Status, challenges and future directions

(2012) Qi Liu et al.   Human Vaccines & Immunotherapeutics

mRNA vaccination as a safe approach for specific protection from type I allergy

(2011) Richard Weiss et al.   Expert Review of Vaccines

Toxoplasma in Animals, Food, and Humans: An Old Parasite of New Concern

(2011) Beniamino T. Cenci-Goga et al.   Foodborne Pathogens and Disease

Induction of protective Th1 immune responses in mice by vaccination with recombinant Toxoplasma gondii nucleoside triphosphate hydrolase-II

(2011) Feng Tan et al.   VACCINE

Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18

(2011) Zi-Guo Yuan et al.   VACCINE

Intranasal vaccination with messenger RNA as a new approach in gene therapy: Use against tuberculosis

(2010) Julio CC Lorenzi et al.   BMC BIOTECHNOLOGY

Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity

(2010) Mariola Fotin-Mleczek et al.   JOURNAL OF IMMUNOTHERAPY

Vaccines against Toxoplasma gondii: challenges and opportunities

(2010) Erik Jongert et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients

(2010) Susanne M Rittig et al.   MOLECULAR THERAPY

Monoclonal antibodies against nucleoside triphosphate hydrolase-II can reduce the replication of Toxoplasma gondii

(2010) Feng Tan et al.   PARASITOLOGY INTERNATIONAL

Functional characterization of in vivo effector CD4+ and CD8+ T cell responses in acute Toxoplasmosis: An interplay of IFN-γ and cytolytic T cells

(2010) Erik Jongert et al.   VACCINE

Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients

(2009) Benjamin Weide et al.   JOURNAL OF IMMUNOTHERAPY

Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers

(2009) David I. Bernstein et al.   VACCINE

Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA

(2008) Benjamin Weide et al.   JOURNAL OF IMMUNOTHERAPY

DNA vaccines: ready for prime time?

(2008) Michele A. Kutzler et al.   NATURE REVIEWS GENETICS